Regadenoson hydrate is an active pharmaceutical ingredient used as a pharmaceutical raw material. It is a polar, polycyclic compound containing multiple hydroxyl groups, an amide, and an amine, existing as a hydrated salt-like form.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Regadenoson hydrate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Regadenoson
pharmaceutical raw material
Quisinostat
pharmaceutical raw material
Quisinostat dihydrochloride
pharmaceutical raw material
Anacetrapib
pharmaceutical raw material
Growth hormone releasing hexapeptide
pharmaceutical raw material
1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide;hydrate
CDQVVPUXSPZONN-WPPLYIOHSA-N
CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N.O
Sourcing Regadenoson hydrate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.